Related Experiment Video
Updated: Jun 8, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
Published on: August 25, 2012
Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group
K P E Glahn1, F R Ellis, P J Halsall
1Danish Malignant Hyperthermia Centre, Department of Anaesthesia, University Hospital Herlev, Copenhagen, Denmark. kpeg@dadlnet.dk
Abstract:
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prompt action. MH crises are very rare and an increasing use of total i.v. anaesthesia is likely to make it even rarer, leading to the potential risk of reduced awareness of MH. In addition, dantrolene, the cornerstone of successful MH treatment, is unavailable in large areas around the world thereby increasing the risk of MH fatalities in these areas. The European Malignant Hyperthermia Group collected and reviewed all guidelines available from the various MH centres in order to provide a consensus document. The guidelines consist of two textboxes: Box 1 on recognizing MH and Box 2 on the treatment of an MH crisis.
More Related Videos
06:43Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023
Related Concept Videos
Increased Body Temperature
Homeostatic Imbalances in Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Hypoglycemia and Glucagon
Types of Fever
Here are the different types of fever:
Acute Pancreatitis II: Clinical Manifestations and Management